Literature DB >> 20601882

Skin infections in developing countries.

Fatma Sule Afsar1.   

Abstract

PURPOSE OF REVIEW: In developing countries, where the majority of people have a low income and live in resource-poor settings, skin infections are prevalent. Data from recent studies provide insight into the most common skin infections and their management. RECENT
FINDINGS: Several studies confirm that skin infections account for the majority of pediatric mortality and morbidity in developing countries. They are prevalent in resource-poor settings and rural areas in certain parts of the world. Also, hot, humid climates and overcrowding predispose to skin infections. Most of the skin infections are curable with effective medication.
SUMMARY: Skin infections are of particular importance in developing countries. This review focuses on the most common skin infections and summarizes the most recent knowledge on the epidemiology, morbidity, and treatment in resource-poor settings.

Entities:  

Mesh:

Year:  2010        PMID: 20601882     DOI: 10.1097/MOP.0b013e32833bc468

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  2 in total

1.  Interactions among urogenital, intestinal, skin, and oral infections in pregnant and lactating Panamanian Ngäbe women: a neglected public health challenge.

Authors:  Doris González-Fernández; Kristine G Koski; Odalis Teresa Sinisterra; Emérita Del Carmen Pons; Enrique Murillo; Marilyn E Scott
Journal:  Am J Trop Med Hyg       Date:  2015-03-30       Impact factor: 2.345

2.  Development, Characterization, and Evaluation of Novel Broad-Spectrum Antimicrobial Topical Formulations from Cymbopogon martini (Roxb.) W. Watson Essential Oil.

Authors:  Negero Gemeda; Ashenif Tadele; Hirut Lemma; Biruktawit Girma; Getachew Addis; Birhanu Tesfaye; Abiy Abebe; Worku Gemechu; Kidist Yirsaw; Frehiwot Teka; Christina Haile; Aliyi Amano; Samuel Woldkidan; Bekesho Geleta; Asfaw Debella
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.